Fingolimod (FTY720) Hinders Interferon-γ-Mediated Fibrotic Scar Formation and Facilitates Neurological Recovery After Spinal Cord Injury
Journal of Neurotrauma · 2023-12 · 40 (23-24) · 2580-2595
DOI: 10.1089/neu.2022.0387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurotrauma, online erschienen am 30.11.2023. Verfasst von Yiteng Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Spinal Cord Injuries. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Following spinal cord injury (SCI), fibrotic scar inhibits axon regeneration and impairs neurological function recovery. It has been reported that T cell–derived interferon (IFN)-γ plays a pivotal role in promoting fibrotic scarring in neurodegenerative disease. However, the role of IFN-γ in fibrotic scar formation after SCI has not been declared. In this study, a spinal cord crush injury mouse was established. Western blot and immunofluorescence showed that IFN-γ was surrounded by fibroblasts at 3, 7, 14, and 28 days post-injury. Moreover, IFN-γ is mainly secreted by T cells after SCI. Further, in situ injection of IFN-γ into the normal spinal cord resulted in fibrotic scar formation and inflammation response at 7 days post-injection. After SCI, the intraperitoneal injection of fingolimod (FTY720), a sphingosine-1-phosphate receptor 1 (S1PR1) modulator and W146, an S1PR1 antagonist, significantly reduced T cell infiltration, attenuating fibrotic scarring via inhibiting IFN-γ/IFN-γR pathway, while in situ injection of IFN-γ diminished the effect of FTY720 on reducing fibrotic scarring. FTY720 treatment inhibited inflammation, decreased lesion size, and promoted neuroprotection and neurological recovery after SCI. These findings demonstrate that the inhibition of T cell-derived IFN-γ by FTY720 suppressed fibrotic scarring and contributed to neurological recovery after SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- Institute of Orthopedics, Research Center for Translational Medicine, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- Scientific Research and Experiment Center, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Zitieren
APA
Li, Y., Chen, Y., Hu, X., Ouyang, F., Li, J., Huang, J., Ye, J., Shan, F., Luo, Y., Yu, S., Li, Z., Yao, F., Liu, Y., Shi, Y., Zheng, M., Cheng, L., & Jing, J. (2023). Fingolimod (FTY720) Hinders Interferon-γ-Mediated Fibrotic Scar Formation and Facilitates Neurological Recovery After Spinal Cord Injury. Journal of Neurotrauma, 40(23-24), 2580-2595. https://doi.org/10.1089/neu.2022.0387
Vancouver
Li Y, Chen Y, Hu X, Ouyang F, Li J, Huang J, et al. Fingolimod (FTY720) Hinders Interferon-γ-Mediated Fibrotic Scar Formation and Facilitates Neurological Recovery After Spinal Cord Injury. Journal of Neurotrauma. 2023;40(23-24):2580-2595. doi:10.1089/neu.2022.0387
BibTeX
@article{Li2023,
author = {Li, Yiteng and Chen, Yihao and Hu, Xuyang and Ouyang, Fangru and Li, Jianjian and Huang, Jinxin and Ye, Jianan and Shan, Fangli and Luo, Yong and Yu, Shuisheng and Li, Ziyu and Yao, Fei and Liu, Yanchang and Shi, Yi and Zheng, Meige and Cheng, Li and Jing, Juehua},
title = {Fingolimod (FTY720) Hinders Interferon-γ-Mediated Fibrotic Scar Formation and Facilitates Neurological Recovery After Spinal Cord Injury},
journal = {Journal of Neurotrauma},
year = {2023},
volume = {40},
number = {23-24},
pages = {2580--2595},
doi = {10.1089/neu.2022.0387}
}
EUVIMED